NextPoint Therapeutics, Inc.

Venture-backed company · Stage unknown· Cambridge, MA
Rounds on record
2
Latest round
Jul 22, 2026
Form D equity offering
Latest round size
$33.7M
Form D industry: Biotechnology
More
Ask DFX about thisView relationshipsFinancing historyInvestorsOwnership and outcomes
As of · the latest observation of this company; each round carries its own date

5 additional officers and directors, 1 additional investor

Every relationship, signal and contact on this record, with the source on each.

Includes 3 days of DFX Intelligence. Then $199/month unless canceled.

What matters now

  1. $33.7M
    sold on Form D

    Filed a Form D on 22 Jul 2026: $33.7M sold on Form D. A Form D is an offering filing; it names no investors, stage or valuation.

    A company that just raised has fresh capital, a new board and new vendors to choose.

    FactSEC Form DFor Investors, lenders, service providersFinancing history →
  2. 2 investors
    named

    2 investors on record.

    The investors already on the cap table shape who leads the next round.

    Factfunding announcements, portfolio pages and Form DFor Investors, foundersInvestors →
  3. 8 directors
    board

    8 directors on record from Form D filings and board-seat attributions.

    The board is who decides on the next round and on a sale.

    FactSEC Form D related personsFor Investors, acquirersPeople →
Drawing the relationship network…
Facts
Year of incorporation
unknown
Revenue range (Form D)
Decline to Disclosesec.gov
Rounds on record
2
Disclosed raised
unknownsum of rounds with a disclosed amount only
Named investors
2
Financing history
2 rounds
  1. Jul 22, 2026
    Form D equity offering · $33.7M (form d sold) · 15 investors
    Fact Form D · “NextPoint Therapeutics, Inc. filed Form D: $33,728,772 sold of $48,729,165, Biotechnology”
  2. Jan 31, 2024
    Form D equity offering · $42.5M (form d sold) · 15 investors
    Catalio Capital Management, LP via R. Jacob Vogelstein
    Fact Form D · “NextPoint Therapeutics, Inc. filed Form D: $42,479,388 sold of $42,479,388, Biotechnology”
Investors on record
4 edges
Ownership and outcomes
none on record
Outcome stated by investors

Listed on 1 firm portfolio page; none states an outcome (acquired, public, exited or active). DFX does not assume the company is active.

Evidence: 1 listingeach firm's own card, as read
No later owner or exit on record: no private equity sponsor position and no acquisition, listing or IPO report names this company.
Credit relationships
none on record
No lender position matched to this company.
People
3 officers, 8 directors
Show all 6 officers and directors
Timeline
2 events
  1. Jul 30, 2026
    NextPoint Therapeutics, Inc. filed Form D: $33,728,772 sold of $48,729,165, Biotechnology
    Form D filed Fact Form D
  2. Feb 14, 2024
    NextPoint Therapeutics, Inc. filed Form D: $42,479,388 sold of $42,479,388, Biotechnology
    Form D filed Fact Form D
Evidence
31 observations
Every observation on this company
  • Entity type: Corporation Jul 30, 2026 Fact Form D
  • Entity type: Corporation Feb 14, 2024 Fact Form D
  • Form D industry group: Biotechnology Jul 30, 2026 Fact Form D
  • Form D industry group: Biotechnology Feb 14, 2024 Fact Form D
  • Amendment: false Jul 30, 2026 Fact Form D
  • Amendment: false Feb 14, 2024 Fact Form D
  • Revenue range (Form D): Decline to Disclose Jul 30, 2026 Fact Form D
  • Revenue range (Form D): Decline to Disclose Feb 14, 2024 Fact Form D
  • Incorporated: overFiveYears Jul 30, 2026 Fact Form D
  • Incorporated: overFiveYears Feb 14, 2024 Fact Form D
  • Jurisdiction: Delaware Jul 30, 2026 Fact Form D
  • Jurisdiction: Delaware Feb 14, 2024 Fact Form D
  • Amount sold (Form D): $33.7M Jul 30, 2026 Fact Form D
  • Amount sold (Form D): $42.5M Feb 14, 2024 Fact Form D
  • Offering amount (Form D): $48.7M Jul 30, 2026 Fact Form D
  • Offering amount (Form D): $42.5M Feb 14, 2024 Fact Form D
  • Exemptions: 06b Jul 30, 2026 Fact Form D
  • Exemptions: 06b Feb 14, 2024 Fact Form D
  • First sale: 2026-07-22 Jul 30, 2026 Fact Form D
  • First sale: 2024-01-31 Feb 14, 2024 Fact Form D
  • Investors (Form D): 15 Jul 30, 2026 Fact Form D
  • Investors (Form D): 15 Feb 14, 2024 Fact Form D
  • Minimum investment (Form D): 0 Jul 30, 2026 Fact Form D
  • Minimum investment (Form D): 0 Feb 14, 2024 Fact Form D
  • Securities offered: Equity, option Jul 30, 2026 Fact Form D
  • Securities offered: equity Feb 14, 2024 Fact Form D
  • Office address: Jul 30, 2026 Fact Form D
  • Office address: Feb 14, 2024 Fact Form D
  • Listed on portfolio page: Sep 30, 2026 Fact no URL
  • Listed on portfolio page: Sep 16, 2026 Fact no URL
  • Listed on portfolio page: Sep 15, 2026 Fact no URL

Relationships across DFX

on 1 other DFX graph
Across the graphs

NextPoint Therapeutics, Inc. is the same institution as 1 record in Private Equity.

Private Equity1

The joined record opens with the product, beside every other relationship on this page.

Checking your plan…

Record history

2 dated events on the change ledger, latest event first
  • Form D filed
    2026-07-30source on record
  • Form D filed
    2024-02-14source on record

The ledger records every merge, rename and reclassification this record went through and the dated filings observed on it, so the identity on this page can be traced to the records it was built from. The ledger's own sentences name other records, so they show with the names.